Risk factors for the different types of chronic lung diseases of prematurity according to the preceding respiratory distress syndrome

Pediatrics International

Volumn 47, Issue 4, 2005, Pages 417-423

  Choi, Chang Won ^b   Kim, Beyong Il ^a   Park, June Dong ^b   Koh, Young Yull ^b   Choi, Jung Hwan ^b   Choi, Jung Yun ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b NONE

Author keywords

Chorioamnionitis; Chronic lung disease; Risk factor

Indexed keywords

LUNG SURFACTANT;

AIRWAY PRESSURE; ARTICLE; CHORIOAMNIONITIS; CHRONIC LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; LOW BIRTH WEIGHT; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PERINATAL PERIOD; POSTMENOPAUSE; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

CHORIOAMNIONITIS; CHRONIC DISEASE; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LOGISTIC MODELS; LUNG DISEASES; MALE; PREGNANCY; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK FACTORS;

EID: 23844540122     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2005.02081.x     Document Type: Article

References (22)

1. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy for hyaline membrane disease. N. Engl. J. Med. 1967; 276: 357-68.
2. Jobe AH, Bancalari E. NICHD/NHLBI/ORD Workshop summary; bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 2001; 163: 1723-9.
3. Wung J, Koons A, Driscoll J, James L. Changing incidence of bronchopulmonary dysplasia. J. Pediatr. 1979; 95: 845-7.
4. Fujimura M, Kitajima H, Nakayama M. Increased leukocyte elastase of the tracheal aspirate at birth and neonatal pulmonary emphysema. Pediatrics 1993; 92: 564-9.
5. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J. Pediatr. 1995; 126: 605-10.
6. Charafeddine L, D'Angio CT, Phelps DL. Atypical chronic lung disease patterns in neonates. Pediatrics 1999; 103: 759-65.
7. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97: 210-15.
8. Speer CP. Inflammatory mechanisms in neonatal chronic lung disease. Eur. J. Pediatr. 1999; 158 (Suppl. 1): S18-22.
9. Yoon BH, Romero R, Kim KS et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am. J. Obstet. Gynecol. 1999; 181: 773-9.
10. Van Marter LJ, Dammann O, Allred EN et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J. Pediatr. 2002; 140: 171-6.
11. Konishi M, Chida S, Shimada S et al. Surfactant replacement therapy in premature babies with respiratory distress syndrome: factors affecting the response to surfactant and comparison of outcome from 1982 to 86 and 1987-91. Acta Paediatr. Jpn. 1992; 34: 617-30.
12. Salafia CM, Weigl C, Silberman L. The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies. Obstet. Gynecol. 1989; 73: 383-9.
13. Takasaki J, Ogawa Y. Interleukin 8 in the tracheobronchial aspirate of infants acts as a neutrophil chemotactic factor in the development of chronic lung disease. Pediatr. Int. 1999; 41: 78-81.
14. Yoon BH, Romero R, Jun JK et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-α, interleukin-1, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am. J. Obstet. Gynecol. 1997; 177: 825-30.
15. Kim BI, Park JD, Yoon BH. Interleukin-8 and neutrophils in the tracheobronchial aspirates at birth and the risk for the development of chronic lung disease of prematurity. Prenat. Neonat. Med. 2000; 5: 375-82.
16. Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. Pediatrics 1999; 104: 1345-50.
17. Naik A, Kallapur S, Bachurski CJ et al. Effects of ventilation with different positive end-expiratory pressure on cytokine expression in the preterm lamb lung. Am. J. Respir. Crit. Care Med. 2001; 164: 494-8.
18. Ikegami M, Jobe AH. Postnatal lung inflammation increased by ventilation of preterm lambs exposed antenatally to Escherichia coli endotoxin. Pediatr. Res. 2002; 52: 356-62.
19. Palta M, Gabbert D, Weinstein MR, Peters ME. Multivariative assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. J. Pediatr. 1991; 119: 285-92.
20. Avery ME, Tooley WH, Keller JB et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987; 79: 26-30.
21. Kraybill EN, Runyan DK, Bose CL, Khan JH. Risk factors for chronic lung disease in very low birth weight neonates. J. Pediatr. 1991; 119: 285-92.
22. Ogawa Y, Takasaki J, Itakura Y, Shimizu H. Epidemiology and classification of chronic lung disease. Pediatr. Pulmonol. 1997; 24 (Suppl. 16): 25-6.